Related Experiment Video
Updated: Jul 12, 2026

Transient Transduction of the Strobilated Forms of Echinococcus granulosus
Published on: September 16, 2022
TREM2 defends the liver against alveolar echinococcosis by driving fibrous shell formation
Meiling Wang1, Hanrui Guo2, Caiya Ni3
1Key Laboratory of Xinjiang Endemic and Ethnic Diseases, Shihezi University School of Medicine, Shihezi, Xinjiang, China; NHC Key Laboratory of Prevention and Treatment of Central Asia High Incidence Diseases, Shihezi University, Shihezi, Xinjiang, China; Department of Pathology, Jinan Maternity and Child Care Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Abstract:
Immunosuppression and extensive fibrosis around the lesions are important features of alveolar echinococcosis (AE) caused by E. multilocularis. Recent studies have suggested that TREM2 is involved in tumor immunosuppression and tissue fibrosis. However, the function and mechanism of TREM2 in AE remain to be determined. Here, TREM2 expression was assessed in human and mouse lesions by immunostaining. A variety of E. multilocularis infection models were established in wild-type and Trem2-/- mice. RNA sequencing, ATAC sequencing, and in vitro assays were conducted to explore the underlying roles of TREM2+ macrophages. Potential drugs were screened and tested in vivo. We show that TREM2+ macrophages accumulated at the periparasitic borders of human and mouse metacestode lesions in the liver. Trem2 deficiency exacerbated the parasitic burden and weakened the fibrous shells surrounding the lesions, whereas Trem2 overexpression enhanced peri-lesional fibrosis in mouse models. E. multilocularis vesicle fluid (EmVF) can induce TREM2 expression via TGF-β/Smad signaling. Trem2 deficiency abolished the macrophage migration and fibroblast proliferation induced by EmVF. Drug screening revealed that resiquimod promoted periparasitic fibrosis, whereas SB431542, a TGF-β signaling inhibitor, had the opposite effect. Thus, TREM2-mediated fibrous shell formation plays a protective role in patients with AE. Activation of TREM2 signaling represents a novel potential therapeutic strategy for AE.
Insights
Triggering TREM2 (T-cell immunoglobulin and mucin-domain containing-3) signaling enhances protective fibrosis in alveolar echinococcosis (AE). This TREM2 pathway activation offers a potential therapeutic strategy for AE, a parasitic disease.
Area of Science:
- Immunology
- Parasitology
- Fibrosis Research
Background:
- Alveolar echinococcosis (AE), caused by E. multilocularis, is characterized by immunosuppression and significant fibrosis.
- The role of TREM2 (T-cell immunoglobulin and mucin-domain containing-3) in AE pathogenesis, particularly in fibrosis and immune response, is not well understood.
Purpose of the Study:
- To investigate the function and mechanism of TREM2 in AE.
- To explore TREM2's role in macrophage behavior and fibrosis formation around E. multilocularis lesions.
- To identify potential therapeutic targets for AE based on TREM2 signaling.
Main Methods:
- Immunostaining of human and mouse AE lesions to assess TREM2 expression.
- Establishment of E. multilocularis infection models in wild-type and Trem2 knockout mice.
- RNA sequencing, ATAC sequencing, and in vitro assays to analyze TREM2+ macrophage function.
- In vivo drug screening targeting TREM2 and TGF-β signaling pathways.
Main Results:
- TREM2+ macrophages were found at the borders of AE lesions in humans and mice.
- TREM2 deficiency worsened parasitic burden and weakened lesion fibrosis, while TREM2 overexpression enhanced fibrosis.
- E. multilocularis vesicle fluid induced TREM2 expression via TGF-β/Smad signaling, promoting macrophage migration and fibroblast proliferation.
- Resiquimod promoted fibrosis, while SB431542 (TGF-β inhibitor) reduced it.
Conclusions:
- TREM2-mediated fibrosis formation plays a crucial protective role in AE.
- Targeting TREM2 signaling presents a promising therapeutic strategy for alveolar echinococcosis.
More Related Videos
Related Concept Videos
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Cirrhosis II: Pathophysiology

